Explor Foods Foodomics EFF Exploration of Foods and Foodomics 2837-9020 Open Exploration Publishing 10.37349/eff.2023.00015 101015 Review Olive oil, fruit and leaves in diabetes mellitus type 2 treatment https://orcid.org/0000-0002-1428-2235 Nosić Mario Data curation Writing—original draft 1 2 https://orcid.org/0000-0003-1822-7767 Waisundara Viduranga Y. Validation Writing—review & editing 3 * https://orcid.org/0000-0002-8680-5007 Banjari Ines Conceptualization Validation Writing—review & editing 1 Iriti Marcello Academic Editor Milan State University, Italy 1Department of Food and Nutrition Research, Faculty of Food Technology, Josip Juraj Strossmayer University of Osijek, 31000 Osijek, Croatia 2Department of Nursing, Faculty of Health Studies, University of Rijeka, 51000 Rijeka, Croatia 3Australian College of Business and Technology at Kandy Campus, Kandy 20000, Sri Lanka *Correspondence: Viduranga Y. Waisundara, Australian College of Business and Technology at Kandy Campus, 670/5, Peradeniya Road, Kandy 20000, Sri Lanka. viduranga@gmail.com 2023 29 10 2023 1 4 192 205 22 08 2023 12 10 2023 © The Author(s) 2023. This is an Open Access article licensed under a Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, sharing, adaptation, distribution and reproduction in any medium or format, for any purpose, even commercially, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.

The Mediterranean dietary pattern, where extra virgin olive oil (EVOO) takes the central spot, is related to longer life expectancy and lower risk of a number of non-communicable diseases, including cardiovascular, diabetes, dementias, and cancer. Positive effect of olive oil on a broad spectrum of diseases, including diabetes mellitus type 2 (DMT2), is usually attributed to its fatty acid content (e.g., oleic acid). Yet, in the last two decades researchers confirmed that, the phenolic compounds (e.g., oleuropein) also significantly alter on glycaemic regulation. Other unprocessed parts of olive plant (fruit and leaves) showed positive impact on glycaemic variability among individuals living with DMT2. The present review focuses on the available research findings on the effect of olive oil, fruits, and leaves on DMT2 treatment. Specifically, the focus is on polyphenols and fats of olive oil, fruits, and leaves with regard to their antidiabetic biological activities.

 Diabetes mellitus type 2 olive oil olive fruit olive leaves fatty acids polyphenols Introduction

Diabetes mellitus is a group of metabolic disorders related to altered metabolism of glucose, protein and lypids which, if untreated, due to hyperglycaemia (elevated glucose concentration in the blood) cause a number of acute and chronic complications. Hyperglycaemia can be a consequence of an absolute or a relative lack of the insuline, insuline resistance, increased glucose formation and of excessive impact of hormones with opposite effects from the insulin on all other organs. The main reason for metabolic abnormalities lies in insufficient effect of insulin on the targeting tissues. There are several patological processes involved in the development of diabetes mellitus, ranging from autoimmune destruction of the pancreatic β-cells with a consequence of apsolute or relative insulin shortage [type 1; diabetes mellitus type 1 (DMT1)] to abnormalities related to insulin resistance (type 2; DMT2). DMT1 affects around 5–10% of individuals while the remaining 90–95% individuals have DMT2 [1].

DMT1 is an autoimmune disease which is a consequence of extraordinary apoptosis of pancreatic β-cells. On the other hand, DMT2 is not an autoimmune disease and has a strong correlation with poor eating habits and excessive consumption of nutritionally low-quality foods (e.g., soft drinks, fast food, candies). Thus, fat and carbohydrate intake are crucial in the development of DMT2 [2].

High-energy daily intake combined with lack of physical activity leads to the development of DMT2. Orientation to a healthy lifestyle is essential for prevention of DMT2 as well as for deterring the development of diabetic complications. Intensive life-style changes are far more effective compared to treatment with oral anti-diabetic treatment regimens such as metformin, and are in correlation with a significant improvement of blood glucose concentration, blood pressure, and blood lipids. If nutritional therapy goals are not achieved in the time period from 3 months to 6 months, it is necessary to introduce pharmacological therapy with the oral anti-diabetic treatments [3, 4]. It has been observed that some integral chemical compounds (e.g., fatty acids, polyphenols) of olive fruit, olive oil, and olive leaves have the ability to lower blood glucose concentrations among persons living with DMT2 and consequently can be very useful in nutritional treatment of DMT2 in a raw form or in the form of various products [5].

Important role in DMT2 pathology has adipokines adiponectin and leptin; their ratio is considered as insulin resistance predictor. When tumor necrosis factor (TNF)-α production of intracellular reactive oxygen species (ROS) is inhibited, adiponectin cannot be suppressed because new amounts of ROS are not produced. TNF-α causes inflammation because it activates transcription factors [e.g., nuclear factor-kappa B (NF-κβ)]. Adiponektin inhibits TNF-α and interleukin (IL) 6. After binding on its cell receptors, adiponektin activates adenosine mono phosphate (AMP)-kinase in the liver and muscles and fatty acid oxidation is increased and triglyceride concentration in the tissue is decreased. Opposite, low concentration of leptin in the bloodstream stimulates food intake [6].

Pancreatic β-cells are extremely sensitive to elevated glucose concentration in the blood stream. Insulin production is decreased because of the chronically elevated glucose concentration which cause β-cell apoptosis. Elevated blood glucose also initiates ROS production through electron transport chain (ETC) and NADPH oxidase. NADPH oxidase could be activated through advanced glycation end products (AGEs) which are common in blood of diabetics. In diabetics ETC is very active which also cause massive deliberation of ROS in the blood stream. In the presence of free fatty acids, ROS was produced and it also reflected on β-cell dysfunction [7].

 Olive oil

Secondary metabolites of olive oil are divided into following categories: aroma compounds, hydrocarbons, sterols, tocopherol and phenols. The most abundant tocopherol in olive oil is α-tocopherol, while β- and γ-tocopherols are found in traces. The content of α-tocopherol in olive oil is influenced by cultivation conditions, olive’s degree of ripeness, storage conditions, and time. Aroma compounds (e.g., hexanal, 2,4-decadienal, 3-carene) are products of oxidative degradation of unsaturated fatty acids. Aliphatic and aromatic hydrocarbons, alcohols, ketons, ethers, and esters are also included in the specific smell and taste of olive oil. Squalen is the most important hydrocarbon in olive oil. It’s a triterpen and intermedier on cholesterol biosynthesis. Besides squalens, olive oil also contains other hydrocarbons [e.g., provitamin A (β-carotene) and lutein] [8].

The most important phytoterol found in olive oil is β-sitosterol which represents 75–90% of total sterols in the olive oil. Campesterol (less than 4%) and stigmasterol (less than 2%), while Δ5-avenasterol can be found at concentrations between 5% and 20%. Few studies showed a positive impact of β-sitosterol on blood glucose concentration in diabetics [9, 10].

Fatty acids

There are many fatty acids found in olive oil, but oleic acid (55% to 83%), palmitic acid (7.5% to 20%), and linoleic acid (3.5% to 21%) are found in the highest concentrations. Other fatty acids found in olive oil, listed in decreasing order are linolenic acid, stearic acid, palmitoleic acid, arachidonic acid, eicosenoic acid, heptadecanoic acid, behenic acid, lignoceric acid, and myristic acid [11–13].

The majority of health benefits attributed to olive oil come from its mono-unsaturated fatty acids (MUFAs; e.g., oleic acid). The Mediterranean diet, abundant in oleic acid (C18:1), in comparison to a diet abundant in linoleic acid, reduces the risk for developing DMT2 and atherosclerosis [14–17]. MUFAs are far more effective in decreasing postprandial glucose level in comparison to poly-unsaturated fatty acids (PUFAs) [18].

Linoleic acid (C18:2) can be found in olive oil in a concentration range from 3.5% to 21% and linoleic acid present in olive oil is present in ≤ 1.0%. The ratio between those two fatty acids should be 5:1 in order to perform eicosanoids (i.e., leukotrienes, lipoxins) synthesis. Eicosanoids are substances similar to hormones and they are usually derived from arachidonic acid [19]. Eicosanoids can be used as markers for predicting the early risk of DMT2 in general [20]. Eicosanoids (e.g., prostaglandins) derived from arachidonic acid have proinflammatory and vasoconstrictive properties, while those derived from eicosapentanoic acid (e.g., leukotrienes) have a weak proinflammatory and vasoconstrictive properties [19]. Eicosanoids are able to prolong the presence of glucose-transporters in the plasma membrane [19, 21]. A high proportion of linoleic acid in foodstuffs in cholesterol esters and in phospholipids can lower the incidence of diabetes [22]. Its concentration correlates significantly with fasting glucose (FG), therefore, it is suggested to substitute animal fats with plant fats [23], and olive oil is often emphasized as the best source of vegetable fats. This change in the contribution of fats from particular food sources can reduce the risk for developing diabetes [24]. When a diet rich in linoleic acid (e.g., sunflower oil) is compared to a diet abundant in oleic acid (e.g., olive oil), FG is lower on a diet rich in oleic acid as compared to linoleic acid diet. Additionally, a diet rich in linoleic acid increases the concentration of low-density lipoprotein (LDL)-cholesterol [16]. Oleic acid protects mitochondria from oxidative stress caused by palmitic acid because it reduces the level of ROS [25]. Extra virgin olive oil (EVOO) regulates postprandial glucose concentration through incretin [e.g., glucagon-like peptide-1 (GLP-1)] excretion and their binding on β-cell receptors [26].

Additionally, insulin resistance in DMT2 is mediated through adipokines and TNF-α, which is produced in fatty tissue and immune system. Hormone adiponectin functions as TNF-α-antagonist and is well known for its insulin-sensitizing properties in the liver and muscles. Adiponectin activates adenosine mono phosphate-activated protein kinase (AMPK) which stimulates oxidative degradation of glucose and fatty acids [27]. Olive oil compounds, namely oleic acid and hydroxytyrosol (HT) individually showed successful results in preventing of adiponectin decrease by itself or in combination. Those effects were better when oleic acid and HT were combined, particularly when they originated from olive oil-incorporating dietary patterns, which is the case in the Mediterranean diet [28].

 Phenolic compounds

Polyphenols (phenolic compounds) are secondary plant metabolites and one of the most abundant in the plant world. There are one or more hydroxyl groups directly attached to one or more aromatic hydrocarbons in their structure. The whole group is named according to their fundamental representative phenol. There are over 8,000 structural variants of phenolic compounds and they can be categorized in the two main groups: flavonoids and non-flavonoids. Flavonoids are one of the most explored among polyphenols with almost 9,000 different flavonoids identified to date. They are divided into various subgroups [flavonols, flavons, isoflavons, flavan-3-ols, flavanons, and anthocyans (including anthocyanidins)]. Representatives of flavonols are quercetin, myricetin, kaempferol, morin, galangin and their glycosides (rutin and astragalin). Their aglycons are not present in plants. Luteolin, apigenin, baikalein, krisin and their glycosydes are considered to be in the group of flavons. Also, naringenin, hesperetin, eriodictol and their glycosides (naringin, hesperidin, liquiritin) are considered to belong to this group of flavonols. Flavan-3-ols are found as simple monomers (e.g., catechins, epigallocatechins, gallocatechins) to complex polymers (proantocyanidins). Antocyans are the major group of flavonoids which have over 600 different compounds. Aglycons of anthocyans are named antocyanidins and in the natural enviroment occur as: pelargonidin, cyanidin, delphinidin, petunidin, and malvidin. Antocyans can be acylated with various hydroxycinnamic acids (e.g., caffeic, p-coumaric, ferulic) and alyphatic acids (e.g., acetic, malic, oxalic). There are two subgroups considered in the group of non-flavonoids: derivatives of hydroxybensoic acid (e.g., vanillic, gallic, m-hydroxybensoic) and derivatives of hydroxycinnamic acid (e.g., p-coumaric acid, ferullic acid, caffeic acid, sinapic and chlorogenic acid) [29–31].

Compared to purified olive oil, EVOO concentration of phenolic compounds is four times higher [32]. Polyphenols from olive oil reduce mitochondrial ROS and therefore, are very useful in the diabetes treatment. Polyphenols from olive leaves have the same effects. Polyphenols encourage the transfer of insulin-regulated glucose transporter-4 (GLUT4) into muscle tissue [33]. EVOO contains higher amounts of squalenes and their components (e.g., oleuropein, tocopherol) compared to purified olive oil [34]. There is an inversed correlation observed between polyphenol intake and FG concentration because they reduce synthesis of AGEs [e.g., hemoglobin A1c (HbA1c)] [35]. Squalenes could have been transformed into cholesterol in the metabolism, but it is not the case because of the excretion in the stool even if daily consumption is high (e.g., 1 g/day). Olive oil phenolic compounds decrease the concentration of proinflammatory molecules (e.g., leucotrienes) [36]. EVOO contains a mixture of polyphenols with one or two hydroxyl groups. After digestion olive oil, polyphenols are bind to LDL-particles and prevent their oxidation [37, 38]. With the consumption of olive oil on a one-time basis, there is a maximal concentration of tyrosol and HT in plasma 2 h after consumption [39, 40].

Individuals diagnosed with metabolic syndrome (MS) often develop DMT2 as a result of insulin resistance. Therefore, it is stated that MS predicts DMT2 and that individuals living with MS are five times more likely to develop DMT2 [41–43]. Virgin olive oil (VOO) polyphenols have a positive influence on MS and consequently on DMT2 [44]. Except oleic acid, certain polyphenols present in olive oil also have favourable effects on human health [45, 46]. Suitable daily intake of polyphenols is positively correlated with the decrease od DMT2 [47–51]. In several early research, health benefits of olive oil were attributed just to MUFAs (oleic acid) but after it a numerous bioactive compounds were taken into consideration (e.g., oleuropein, caffeic acid, HT, and luteolin) [52–54]. EVOO, based on its oleuropein content, reduces postprandial blood glucose concentration [55, 56]. Daily consumption of 20 mL of EVOO increased the concentration of GLP-1 [57, 58]. An increased concentration of GLP-1 consequently decreases the level of ROS [59]. Exenatide was the first GLP-1 receptor agonist (RA) used in DMT2 treatment [60]. GLP-1 is a gastrointestinal incretin hormone which concentration is very low in the period of fasting and increases after food consumption especially after glucose intake [57, 61]. EVOO is able to increase insulin sensitivity, and reduces dipeptidyl peptidase-4 activity which consequently elevates GLP-1 [62, 63]. The daily intake of EVOO and diabetes mellitus are in an opposite correlation [64]. Adults suffering from cardiovascular diseases (CVDs) had a 40% significantly decreased risk of DMT2 in the 4 years period of intake [65]. Individuals consuming olive oil have significantly decreased the risk of developing DMT2 compared to those consuming sunflower oil [66]. Oleuropein is present in much greater concentration in EVOO compared to ordinary olive oil. This phenolic compound has postprandial glucose lowering properties [67, 68]. Individuals living with DMT2 were treated with polyphenol-free olive oil during four weeks and after that with EVOO abundant on polyphenols. All patients were overweight. EVOO had a significant correlation with the decrease of FG as well as with the decrease of HbA1c. There were only 11 patients in this particular study [64, 69]. Oleuropein is able to inhibit GLUT2 transporters [70–73]. Research done on 25 individuals living with DMT2 showed a decrease of postprandial glucose concentration in the blood. In this research, ordinary chocolate was compared to chocolate combined with EVOO. Polyphenol oleuropein from olive oil has a notable relevance in lowering postprandial glucose level and it is of great interest regarding the glycaemic control [74]. Oleuropein, HT and tyrosol are hydrolytic degradation products [54]. HT is very stable in alimentary tract and has high bioaccessibility in the organism. HT, tyrosol, and their derivatives build up to 90% of total polyphenols in olive oil [75]. VOO which is used in the Mediterranean diet regulates glucose concentration in the blood and consequently the occurrence of DMT2 [76]. For each increase of 10 g/day of olive oil there is a 9% decrease of DMT2 development, but there is no effect in daily intake above 15 g [69]. Research on EVOO showed a significant correlation between glucose concentration and HbA1c concentration in the blood after 56 days of EVOO daily intake. Adipokines (visfatin and apelin) have possible effects on glucose metabolism. Visfatin is elevated among individuals living with DMT2. EVOO showed decreasing properties in modification of visfatin concentration in the blood [64]. That consequently leads to a decrease of HbA1c concentration in the blood which is crucial because 1% increase of HbA1c concentration causes 28% increase of general mortality [77]. The Mediterranean diet, supplemented with EVOO, decreases glucose concentration in the blood [78]. DMT2 and the MS are in significant correlation because individuals suffering from MS are in great probability to develop DMT2 [79, 80]. Among 13 individuals living with MS, the consumption of EVOO decreased blood glucose concentration [81].

Positive effect of EVOO on lowering blood glucose is related to postprandial increase of GLP-1 and a decrease of lipopolysaccharide (LPS). Because of changes in the gut permeability, low-grade endotoxemia (LGE) is consequently decreased. LGE is a consequence of tight junction (TJ) proteins modifications. TJ proteins are modified when concentrations of LPS and zonulin are decreased which enhances gut permeability [62, 82, 83]. One research including 1,282 individuals living with DMT2 showed that the Mediterranean diet supplemented with EVOO is able to prevent retinopathy [84]. Oleuropein and HT can inhibit glucose transporter 2 [85].

 Olive fruit

Olive fruit contains 15–35% of olive oil [86]. Chemical components in table olives are presented in Table 1. Olive fruit contains vitamins soluble in water (C, B1, B2, B5, B6, B9) as well as vitamins soluble in fat (A and E). Olive fruit contain minerals: magnesium, calcium, iron, and potassium. Phenolic compounds tyrosol and HT are also present in olive leaves. Tyrosol and HT are categorised as phenolic alcohols and are among the main compounds which can be found in olive fruit. HT with elenolic acid forms secoiridoid compound oleuropein is specific for the family Oleaceae [87]. Oleuropein is also found in leaves in 3,000 higher concentration. Oleuropein reduces glucose concentration in the blood as well as lipid concentration. Oleuropein is also a component of EVOO [70]. Obese men who received oleuropein capsules (51 mg/day) showed a significant improvement in β-cell functioning and post-prandial glucose concentration [88]. In another conducted research, oleuropein in capsules (35–200 mg/day), decreased the concentration of blood glucose after sucrose intake [71]. Subjects who consumed oleuropein supplements had lower postprandial glucose concentration in comparison to those who were given no supplements [89]. Even patients who consumed oleuropein enriched chocolate (with EVOO) had a lower postprandial glucose level in comparison to patients who ate no oleuropein enriched chocolate [74]. Oleuropein 60-day treatment (100 mg/day) decreases blood glucose in diabetics [71]. Oleuropein has an impact on gut microbiota and consequently on DMT2. That property also has HT from olive leaves [90]. Phenolic compounds are abundant in olive fruit tissue and are mostly soluble in water. They can also be found in olive oil but in very low concentration. Concentration of phenolic compounds depends on the degree of ripeness of the fruit. Levels of luteolin, tyrosol, and HT increase with olive fruit’s degree of ripeness. HT inhibits the occurrence of pro-inflammatory leukotriene B4. Polyphenols are able to inhibit carbohydrate absorption and consequently postprandial glucose concentration in the blood [91]. When vitamin E is consumed in natural occurring foodstuffs (e.g., natural olive oil), compared to supplements, its effects are much better (or symbiotic) because of the presence of various secondary metabolites [92]. Although the olive fruit has a low concentration of proteins (1–3%), their nutritional value is very important. That is because of the content of essential amino acids (e.g., leucine, isoleucine, lysine) [93]. Dietary fibre components in olive fruit are mainly pectin, hemicellulose, and cellulose. Pectin is classified as water soluble dietary fibre, cellulose as water insoluble dietary fibre and hemicellulose as partially soluble dietary fibre [94]. Soluble dietary fibres, because of their viscosity, increase intestinal transit time and in that way can decrease glucose concentration in the blood. Postprandial glucose lowering effect cannot be observed with consumption of water insoluble dietary fibre [95, 96].

Chemical composition of the olive fruit [86]

Component %
MUFAs 60–80
Water 50–70
Saturated fatty acids 12–20
Fat 18–35
Total sugar 18
Reducing sugar 2–6
PUFAs 5–18
Minerals 1–5
Potassium 0.5–3.4
Dietary fiber 1–3
Proteins 1–3
Cellulose 1.5–2
Hydrocarbons 0.8–1
Polyphenols 0.5–0.8
Tocopherols 0.3–0.8
Phosphorous 0.02–0.25
Calcium 0.02–0.20
Sodium 0.01–0.20
Sulphur 0.01–0.13
Olive leaves

Olive leaf extracts (OLEs) lower postprandial glucose concentration in the blood. Olive leaves have another impact on human organism compared to olive oil. The positive effects of olive leaves are mainly attributed to the following compounds: oleuropein, oleanolic acid, oleacein, erythrodiol, tyrosol, HT; oleuropein obtained from OLEs regulates glucose concentration in the blood because it affects insulin receptor substrates (IRSs), especially IRS1 and IRS2. After phosphorylation, those substrates activate serine/threonine kinase protein kinase B (Akt/PKB) and stimulate glucose entrance in the cells [97]. In a study conducted with olive leaf tea, the results on healthy individuals showed a significant decrease of blood glucose concentration related with decreased time of starch degradation due to α-amylase inhibition [98]. Oleuropein inhibits differentiation of adipocytes. In a clinical trial among 41 patients (27 men and 14 women) those who drank olive leaves tea for 14 weeks had a much lower concentration of HbA1c compared to those not drinking olive leaf tea at all [97]. The usage of 500 mg OLE for 7 days significantly decreased HbA1c concentration in DMT2 patients [99]. Oleanolic acid is also very important triterpenoid present in olive leaves and has antidiabetic properties. It inhibits α-glucosidase. Isomer of oleanolic acid is ursolic acid (UA). Oleanolic acid and UA are able to inhibit gluconeogenesis in the liver. Oleanolic acid derivative bardoxolone methyl showed a positive impact on DMT2 patients suffering from chronic kidney disease (CKD) [99].

 Suggestions for further research

Most studies reviewed here were in vitro and animal studies. However, the potential of various components of olive oil, fruits, and/or leaves is evident and more randomized clinical trials on human subjects are needed. Available findings of various olive plant products in patients with DMT2 or MS are summerized in Table 2. It is especially important to conduct human studies which will be able to determine whether the observed beneficial effect of olive oil is specific only to its consumption or is it rather the combined effect in the Mediterranean diet [100]. Surely, lifestyle, from physical activity [101] to sleep patterns and psychological condition [102] can alter blood glucose, therefore well designed studies are needed to examine the role of olive oil on gylcaemia. Also, the potential of olive oil on some types of cancer shed a new light on its health benefits [103].

Overview of human studies involving various olive plant products

Product of olive plant Food component concentration Treatment (duration, number of participants, gender, age) Effect/main outcome Reference
EVOO 10 g EVOO in meal

Postprandial blood sample was collected at 1:00 PM (before lunch), and 60 min and 120 min after lunch (proteins: 16–19%; carbohydrates: 53–54%; fats: 28–30%)

30 IFG patients

Gender: 17 males and 13 females

Age: 58.1 years ± 11.4 years

20% decrease of blood glucose and insulin

Δ change 18 mg/dL

 [48]
EVOO

EVOO, 25mL/day (577 mg phenolic compound/kg)

ROO, 25 mL/day (polyphenols not detectable)

11 overweight DMT2 patients

First four weeks “wash out” period—only ROO. Remaining four weeks EVOO (high in polyphenols)

Gender: 7 men and 4 postmenopausal women

Age: 64.63 years ± 8.52 years

 EVOO significantly reduced fasting plasma glucose (P = 0.023), HbA1c (P = 0.039), BMI (P = 0.012), and body weight (P = 0.012) [55]
Oleuropein enriched chocolate 40 g oleuropein eriched chocolate and Mediterranean eating pattern (long before and during clinical trial)

25 DMT2 patients (compared to 20 healthy patients; 10 males/10 females; age: 33.9 years ± 6.9 years)

Gender: 12 males and 13 females

Age: 69 years ±8 years

After washout period (10 days) participants took oleuropein non- enriched chocolate

 Administration of 40 g oleuropein enriched chocolate is associated with modest or no increase of glycaemia DMT2 patients and healthy subjects [65]
EVOO 10 mL/day at lunch and dinner

13 patients suffering from MS

Gender: 5 males and 8 females

Age: 51.9 years ± 7.4 years

Measures was conducted at the beginning and after 90 days

 After 90 days of the study blood glucose decreased from average 93 mg/dL to average 86.0 mg/dL [72]
Capsules with OLE

Period of 12 weeks

Single dose (4 capsules) contains 51.1 g oleuropein and 9.7 mg HT

45 overweight patients

Gender: only men

Age: 46.4 years ± 5.5 years

Participants received 4 capsules with OLEs as a single dose 12 weeks once a day

 After 12 weeks supplementation insulin sensitivity was significantly improved compared to placebo group (P = 0.009) [79]
Capsules with olive leaf and fruit extracts

Period of 2 months

Single dose (2 capsules) contains 100 mg/day oleuropein and 20 mg/day HT

663 patients suffering from hypertension—134 prediabetic and 44 diabetic

Gender: 327 males and 336 female

Age: 60 years ± 12 years

2 months supplementation

 After 2 months supplementation FG was significantly improved (with a decrease of 4.8%), P ˂ 0.0001 [62]
Capsule with OLE

Period of 14 weeks

Single dose (1 capsule) contains 500 mg OLE

41 patient suffering from DMT2

Gender: 27 males and 14 females

Age: 18–79 years

14 weeks supplementation

 After 14 weeks supplementation HbA1c was significantly lower (compared to placebo group) [88]

BMI: body mass index; IFG: impaired fasting glucose; P: the level of statistical significance; ROO: refined olive oil

 Conclusions

Olive oil, especially extra virgin, was found to be effective for glycaemic control in individuals with DMT2. These benefits are primarily attributed to fatty acid and phenolic composition of olive oil. Still, the majority of these findings, especially in terms of lower DMT2 risk in olive oil consumers come from observational (cohort) studies focused on the Mediterranean diet as a whole. Therefore, more randomized clinical trials are needed to elucidate which components of olive oil expose the strongest effect on glycaemia control. Other parts of olive, both fruits and leaves (consumed as a tea) were found to have the same beneficial effect on hyperglycaemia, but there is insufficient number of human studies to provide conclusive evidence. More studies are needed, especially human studies, which will not only strengthen current recommendations to include olive oil in daily diet, but potentially lead to the development of new pharmacological solutions (especially in regard to exploiting olive leaves) to aid public health crisis of diabetes the world is facing.

 Abbreviations DMT2

diabetes mellitus type 2

 EVOO

extra virgin olive oil

 FG

fasting glucose

 GLP-1

glucagon-like peptide-1

 HbA1c

hemoglobin A1c

 HT

hydroxytyrosol

 IRSs

insulin receptor substrates

 MS

metabolic syndrome

 MUFAs

mono-unsaturated fatty acids

 OLEs

olive leaf extracts

 ROS

reactive oxygen species

 TNF

tumor necrosis factor

 Declarations Author contributions

MN: Data curation, Writing—original draft. VYW: Validation, Writing—review & editing. IB: Conceptualization, Validation, Writing—review & editing. All authors read and approved the final version of the manuscript.

 Conflicts of interest

No potential conflicts of interest were reported by the authors.

 Ethical approval

Not applicable.

 Consent to participate

Not applicable.

 Consent to publication

Not applicable.

 Availability of data and materials

Not applicable.

 Funding

Not applicable.

 Copyright

© The Author(s) 2023.

 Petersmann A Müller-Wieland D Müller UA Landgraf R Nauck M Freckmann G et al. Definition, classification and diagnosis of diabetes mellitus Exp Clin Endocrinol Diabetes 2019 127 S1 7 10.1055/a-1018-907831860923 Marzo N Mora C Fabregat ME Martín J Usac EF Franco C et al. Pancreatic islets from cyclin-dependent kinase 4/R24C (Cdk4) knockin mice have significantly increased beta cell mass and are physiologically functional, indicating that Cdk4 is a potential target for pancreatic beta cell mass regeneration in type 1 diabetes Diabetologia 2004 47 686 94 10.1007/s00125-004-1372-015298346 Look AHEAD Research Group Wing RR Long-term effects of a lifestyle intervention on weight and cardiovascular risk factors in individuals with type 2 diabetes mellitus: four-year results of the Look AHEAD trial Arch Intern Med 2010 170 1566 75 10.1001/archinternmed.2010.33420876408PMC3084497 Knowler WC Barrett-Connor E Fowler SE Hamman RF Lachin JM Walker EA et al. Diabetes Prevention Program Research Group Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin N Engl J Med 2002 346 393 403 10.1056/NEJMoa01251211832527PMC1370926 Zheng S Huang K Tong T Efficacy and mechanisms of oleuropein in mitigating diabetes and diabetes complications J Agric Food Chem 2021 69 6145 55 10.1021/acs.jafc.1c0140434042426 Ruan H Miles PD Ladd CM Ross K Golub TR Olefsky JM et al. Profiling gene transcription in vivo reveals adipose tissue as an immediate target of tumor necrosis factor-α: implications for insulin resistance Diabetes 2002 51 3176 88 10.2337/diabetes.51.11.317612401708 Kaneto H Katakami N Matsuhisa M Matsuoka TA Role of reactive oxygen species in the progression of type 2 diabetes and atherosclerosis Mediators Inflamm 2010 2010 453892 10.1155/2010/45389220182627PMC2825658 Boskou D Olive oil: chemistry and technology 2nd ed Thessaloniki AOCS Press 2006 Radika MK Viswanathan P Anuradha CV Nitric oxide mediates the insulin sensitizing effects of β-sitosterol in high fat diet-fed rats Nitric Oxide 2013 32 43 53 10.1016/j.niox.2013.04.00723624268 Gupta R Sharma AK Dobhal MP Sharma MC Gupta RS Antidiabetic and antioxidant potential of β-sitosterol in streptozotocin-induced experimental hyperglycemia J Diabetes 2011 3 29 37 10.1111/j.1753-0407.2010.00107.x21143769 Owen RW Giacosa A Hull WE Haubner R Würtele G Spiegelhalder B et al. Olive-oil consumption and health: the possible role of antioxidants Lancet Oncol 2000 1 107 12 10.1016/s1470-2045(00)00015-211905662 International Olive Council [Internet] Trade standard applying to olive oils and olive pomace oils; 2019 [cited 2023 Feb 15]. Available from: https://www.internationaloliveoil.org/wp-content/uploads/2019/12/trade-standard-REV-14-Eng.pdf Saini RK Keum YS Omega-3 and omega-6 polyunsaturated fatty acids: dietary sources, metabolism, and significance—a review Life Sci 2018 203 255 67 10.1016/j.lfs.2018.04.04929715470 Meijaard E Abrams JF Slavin JL Sheil D Dietary fats, human nutrition and the environment: balance and sustainability Front Nutr 2022 9 878644 10.3389/fnut.2022.87864435548568PMC9083822 Field CJ Robinson L Dietary fats Adv Nutr 2019 10 722 4 10.1093/advances/nmz05231147674PMC6628852 Madigan C Ryan M Owens D Collins P Tomkin GH Dietary unsaturated fatty acids in type 2 diabetes: higher levels of postprandial lipoprotein on a linoleic acid-rich sunflower oil diet compared with an oleic acid-rich olive oil diet Diabetes Care 2000 23 1472 7 10.2337/diacare.23.10.147211023139 Schulze MB Hu FB Primary prevention of diabetes: what can be done and how much can be prevented? Annu Rev Public Health 2005 26 445 67 10.1146/annurev.publhealth.26.021304.14453215760297 Qian F Korat AA Malik V Hu FB Metabolic effects of monounsaturated fatty acid-enriched diets compared with carbohydrate or polyunsaturated fatty acid-enriched diets in patients with type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials Diabetes Care 2016 39 1448 57 10.2337/dc16-051327457635PMC4955926 De Caterina R Madonna R Bertolotto A Schmidt EB n-3 fatty acids in the treatment of diabetic patients: biological rationale and clinical data Diabetes Care 2007 30 1012 26 10.2337/dc06-133217251279 Tuomisto K Palmu J Long T Watrous JD Mercader K Lagerborg KA et al. A plasma metabolite score of three eicosanoids predicts incident type 2 diabetes: a prospective study in three independent cohorts BMJ Open Diabetes Res Care 2022 10 e002519 10.1136/bmjdrc-2021-00251935361620PMC8971778 Manco M Calvani M Mingrone G Effects of dietary fatty acids on insulin sensitivity and secretion Diabetes Obes Metab 2004 6 402 13 10.1111/j.1462-8902.2004.00356.x15479216 Wang L Folsom AR Zheng ZJ Pankow JS Eckfeldt JH ARIC Study Investigators Plasma fatty acid composition and incidence of diabetes in middle-aged adults: the Atherosclerosis Risk in Communities (ARIC) Study Am J Clin Nutr 2003 78 91 8 10.1093/ajcn/78.1.9112816776 Laaksonen DE Lakka TA Lakka HM Nyyssönen K Rissanen T Niskanen LK et al. Serum fatty acid composition predicts development of impaired fasting glycaemia and diabetes in middle-aged men Diabet Med 2002 19 456 64 10.1046/j.1464-5491.2002.00707.x12060056 Harding AH Day NE Khaw KT Bingham S Luben R Welsh A et al. Dietary fat and the risk of clinical type 2 diabetes: the European prospective investigation of Cancer-Norfolk study Am J Epidemiol 2004 159 73 82 10.1093/aje/kwh00414693662 Palomer X Pizarro-Delgado J Barroso E Vázquez-Carrera M Palmitic and oleic acid: the yin and yang of fatty acids in type 2 diabetes mellitus Trends Endocrinol Metab 2018 29 178 90 10.1016/j.tem.2017.11.00929290500 Smilowitz NR Donnino R Schwartzbard A Glucagon-like peptide-1 receptor agonists for diabetes mellitus: a role in cardiovascular disease Circulation 2014 129 2305-12 10.1161/CIRCULATIONAHA.113.00698524891623 Ruan H Dong LQ Adiponectin signaling and function in insulin target tissues J Mol Cell Biol 2016 8 101 9 10.1093/jmcb/mjw01426993044PMC4816150 Scoditti E Massaro M Carluccio MA Pellegrino M Wabitsch M Calabriso N et al. Additive regulation of adiponectin expression by the mediterranean diet olive oil components oleic acid and hydroxytyrosol in human adipocytes PLoS One 2015 10 e0128218 10.1371/journal.pone.012821826030149PMC4452359 Pandey KB Rizvi SI Plant polyphenols as dietary antioxidants in human health and disease Oxid Med Cell Longev 2009 2 897484 10.4161/oxim.2.5.949820716914PMC2835915 Huang WY Cai YZ Zhang Y Natural phenolic compounds from medicinal herbs and dietary plants: potential use for cancer prevention Nutr Cancer 2009 62 1 20 10.1080/0163558090319158520043255 Tsao R Chemistry and biochemistry of dietary polyphenols Nutrients 2010 2 1231 46 10.3390/nu212123122254006PMC3257627 Owen RW Mier W Giacosa A Hull WE Spiegelhalder B Bartsch H Phenolic compounds and squalene in olive oils: the concentration and antioxidant potential of total phenols, simple phenols, secoiridoids, lignansand squalene Food Chem Toxicol 2000 38 647 59 10.1016/s0278-6915(00)00061-210908812 Anderson RE Tan WK Martin HS Meyer FB Effects of glucose and PaO2 modulation on cortical intracellular acidosis, NADH redox state, and infarction in the ischemic penumbra Stroke 1999 30 160 70 10.1161/01.str.30.1.1609880405 Servili M Sordini B Esposto S Urbani S Veneziani G Di Maio I et al. Biological activities of phenolic compounds of extra virgin olive oil Antioxidants (Basel) 2014 3 1 23 10.3390/antiox301000126784660PMC4665453 Xiao JB Högger P Dietary polyphenols and type 2 diabetes: current insights and future perspectives Curr Med Chem 2015 22 23 38 10.2174/092986732166614070613080725005188 Vieira O Laranjinha J Madeira V Almeida L Cholesteryl ester hydroperoxide formation in myoglobin-catalyzed low density lipoprotein oxidation: concerted antioxidant activity of caffeic and p-coumaric acids with ascorbate Biochem Pharmacol 1998 55 333 40 10.1016/s0006-2952(97)00470-x9484800 Leenen R Roodenburg AJ Vissers MN Schuurbiers JA van Putte KP Wiseman SA et al. Supplementation of plasma with olive oil phenols and extracts: influence on LDL oxidation J Agric Food Chem 2002 50 1290 7 10.1021/jf010968u11853520 Perona JS Cabello-Moruno R Ruiz-Gutierrez V The role of virgin olive oil components in the modulation of endothelial function J Nutr Biochem 2006 17 429 45 10.1016/j.jnutbio.2005.11.00716481154 Miró-Casas E Farré Albaladejo M Covas MI Rodriguez JO Menoyo Colomer E Lamuela Raventós RM et al. Capillary gas chromatography-mass spectrometry quantitative determination of hydroxytyrosol and tyrosol in human urine after olive oil intake Anal Biochem 2001 294 63 72 10.1006/abio.2001.516011412007 Covas MI Nyyssönen K Poulsen HE Kaikkonen J Zunft HJ Kiesewetter H et al. EUROLIVE Study Group The effect of polyphenols in olive oil on heart disease risk factors: a randomized trial Ann Intern Med 2006 145 333 41 10.7326/0003-4819-145-5-200609050-0000616954359 Kassi E Pervanidou P Kaltsas G Chrousos G Metabolic syndrome: definitions and controversies BMC Med 2011 9 48 10.1186/1741-7015-9-4821542944PMC3115896 Ford ES Li C Sattar N Metabolic syndrome and incident diabetes: current state of the evidence Diabetes Care 2008 31 1898 904 10.2337/dc08-042318591398PMC2518368 Stern MP Williams K González-Villalpando C Hunt KJ Haffner SM Does the metabolic syndrome improve identification of individuals at risk of type 2 diabetes and/or cardiovascular disease? Diabetes Care 2004 27 2676 81 10.2337/diacare.27.11.267615505004 Shin JA Lee JH Lim SY Ha HS Kwon HS Park YM et al. Metabolic syndrome as a predictor of type 2 diabetes, and its clinical interpretations and usefulness J Diabetes Investig 2013 4 334 43 10.1111/jdi.1207524843675PMC4020225 Covas MI de la Torre R Fitó M Virgin olive oil: a key food for cardiovascular risk protection Br J Nutr 2015 113 S19 28 10.1017/S000711451500013626148918 Martín-Peláez S Covas MI Fitó M Kušar A Pravst I Health effects of olive oil polyphenols: recent advances and possibilities for the use of health claims Mol Nutr Food Res 2013 57 760 71 10.1002/mnfr.20120042123450515 Grosso G Stepaniak U Micek A Stefler D Bobak M Pająk A Dietary polyphenols are inversely associated with metabolic syndrome in Polish adults of the HAPIEE study Eur J Nutr 2017 56 1409 20 10.1007/s00394-016-1187-z26913852PMC5486632 Amiot MJ Riva C Vinet A Effects of dietary polyphenols on metabolic syndrome features in humans: a systematic review Obes Rev 2016 17 573 86 10.1111/obr.1240927079631 Sun Q Wedick NM Pan A Townsend MK Cassidy A Franke AA et al. Gut microbiota metabolites of dietary lignans and risk of type 2 diabetes: a prospective investigation in two cohorts of U.S. women Diabetes Care 2014 37 1287 95 10.2337/dc13-251324550220PMC3994932 Zamora-Ros R Forouhi NG Sharp SJ González CA Buijsse B Guevara M et al. Dietary intakes of individual flavanols and flavonols are inversely associated with incident type 2 diabetes in European populations J Nutr 2014 144 335 43 10.3945/jn.113.18494524368432PMC3927546 Wedick NM Pan A Cassidy A Rimm EB Sampson L Rosner B et al. Dietary flavonoid intakes and risk of type 2 diabetes in US men and women Am J Clin Nutr 2012 95 925 33 10.3945/ajcn.111.02889422357723PMC3302366 Mirarchi L Amodeo S Citarrella R Licata A Soresi M Giannitrapani L SGLT2 inhibitors as the most promising influencers on the outcome of non-alcoholic fatty liver disease Int J Mol Sci 2022 23 3668 10.3390/ijms2307366835409028PMC8998221 Marrano N Spagnuolo R Biondi G Cignarelli A Perrini S Vincenti L et al. Effects of extra virgin olive oil polyphenols on beta-cell function and survival Plants (Basel) 2021 10 286 10.3390/plants1002028633546278PMC7913337 Pedan V Popp M Rohn S Nyfeler M Bongartz A Characterization of phenolic compounds and their contribution to sensory properties of olive oil Molecules 2019 24 2041 10.3390/molecules2411204131142034PMC6600435 Mousavi S Mariotti R Stanzione V Pandolfi S Mastio V Baldoni L et al. Evolution of extra virgin olive oil quality under different storage conditions Foods 2021 10 1945 10.3390/foods1008194534441722PMC8391879 Jimenez-Lopez C Carpena M Lourenço-Lopes C Gallardo-Gomez M Lorenzo JM Barba FJ et al. Bioactive compounds and quality of extra virgin olive oil Foods 2020 9 1014 10.3390/foods908101432731481PMC7466243 Carnevale R Loffredo L Del Ben M Angelico F Nocella C Petruccioli A et al. Extra virgin olive oil improves post-prandial glycemic and lipid profile in patients with impaired fasting glucose Clin Nutr 2017 36 782 7 10.1016/j.clnu.2016.05.01627289163 Mandøe MJ Hansen KB Hartmann B Rehfeld JF Holst JJ Hansen HS The 2-monoacylglycerol moiety of dietary fat appears to be responsible for the fat-induced release of GLP-1 in humans Am J Clin Nutr 2015 102 548 55 10.3945/ajcn.115.10679926178726 Nauck MA Quast DR Wefers J Meier JJ GLP-1 receptor agonists in the treatment of type 2 diabetes – state-of-the-art Mol Metab 2021 46 101102 10.1016/j.molmet.2020.10110233068776PMC8085572 Melo M Gavina C Silva-Nunes J Andrade L Carvalho D Heterogeneity amongst GLP-1 RA cardiovascular outcome trials results: can definition of established cardiovascular disease be the missing link? Diabetol Metab Syndr 2021 13 81 10.1186/s13098-021-00698-534315528PMC8317280 Zappas MP Gentes M Walton-Moss B Use of incretin therapy in the treatment of type 2 diabetes mellitus J Nurse Pract 2017 13 418 24 10.1016/j.nurpra.2016.08.023 Carnevale R Pastori D Nocella C Cammisotto V Baratta F Del Ben M et al. Low-grade endotoxemia, gut permeability and platelet activation in patients with impaired fasting glucose Nutr Metab Cardiovasc Dis 2017 27 890 5 10.1016/j.numecd.2017.06.00728743559 Esposito K Marfella R Ciotola M Di Palo C Giugliano F Giugliano G et al. Effect of a mediterranean-style diet on endothelial dysfunction and markers of vascular inflammation in the metabolic syndrome: a randomized trial JAMA 2004 292 1440 6 10.1001/jama.292.12.144015383514 Santangelo C Filesi C Varì R Scazzocchio B Filardi T Fogliano V et al. Consumption of extra-virgin olive oil rich in phenolic compounds improves metabolic control in patients with type 2 diabetes mellitus: a possible involvement of reduced levels of circulating visfatin J Endocrinol Invest 2016 39 1295 301 10.1007/s40618-016-0506-927344308 Storniolo CE Casillas R Bulló M Castañer O Ros E Sáez GT et al. A Mediterranean diet supplemented with extra virgin olive oil or nuts improves endothelial markers involved in blood pressure control in hypertensive women Eur J Nutr 2017 56 89 97 10.1007/s00394-015-1060-526450601 Soriguer F Rojo-Martínez G Goday A Bosch-Comas A Bordiú E Caballero-Díaz F et al. Olive oil has a beneficial effect on impaired glucose regulation and other cardiometabolic risk factors. Di@bet.es study Eur J Clin Nutr 2013 67 911 6 10.1038/ejcn.2013.13023859999 Ahamad J Toufeeq I Khan MA Ameen MSM Anwer ET Uthirapathy S et al. Oleuropein: a natural antioxidant molecule in the treatment of metabolic syndrome Phytother Res 2019 33 3112 28 10.1002/ptr.651131746508 Bulotta S Celano M Lepore SM Montalcini T Pujia A Russo D Beneficial effects of the olive oil phenolic components oleuropein and hydroxytyrosol: focus on protection against cardiovascular and metabolic diseases J Transl Med 2014 12 219 10.1186/s12967-014-0219-925086598PMC4237885 Schwingshackl L Lampousi AM Portillo MP Romaguera D Hoffmann G Boeing H Olive oil in the prevention and management of type 2 diabetes mellitus: a systematic review and meta-analysis of cohort studies and intervention trials Nutr Diabetes 2017 7 e262 10.1038/nutd.2017.1228394365PMC5436092 Da Porto A Brosolo G Casarsa V Bulfone L Scandolin L Catena C et al. The pivotal role of oleuropein in the anti-diabetic action of the mediterranean diet: a concise review Pharmaceutics 2021 14 40 10.3390/pharmaceutics1401004035056936PMC8778910 Hermans MP Lempereur P Salembier JP Maes N Albert A Jansen O et al. Supplementation effect of a combination of olive (Olea europea L.) leaf and fruit extracts in the clinical management of hypertension and metabolic syndrome Antioxidants (Basel) 2020 9 872 10.3390/antiox909087232942738PMC7554871 Kellett GL Brot-Laroche E Apical GLUT2: a major pathway of intestinal sugar absorption Diabetes 2005 54 3056 62 10.2337/diabetes.54.10.305616186415 Ali MS Jahangir M Hussan SS Choudhary MI Inhibition of α-glucosidase by oleanolic acid and its synthetic derivatives Phytochemistry 2002 60 295 9 10.1016/s0031-9422(02)00104-812031449 Del Ben M Nocella C Loffredo L Bartimoccia S Cammisotto V Mancinella M et al. Oleuropein-enriched chocolate by extra virgin olive oil blunts hyperglycaemia in diabetic patients: results from a one-time 2-hour post-prandial cross over study Clin Nutr 2020 39 2187 91 10.1016/j.clnu.2019.09.00631585740 Vissers MN Zock PL Katan MB Bioavailability and antioxidant effects of olive oil phenols in humans: a review Eur J Clin Nutr 2004 58 955 65 10.1038/sj.ejcn.160191715164117 Lasa A Miranda J Bulló M Casas R Salas-Salvadó J Larretxi I et al. Comparative effect of two Mediterranean diets versus a low-fat diet on glycaemic control in individuals with type 2 diabetes Eur J Clin Nutr 2014 68 767 72 10.1038/ejcn.2014.124518752 Khaw KT Wareham N Luben R Bingham S Oakes S Welch A et al. Glycated haemoglobin, diabetes, and mortality in men in Norfolk cohort of european prospective investigation of cancer and nutrition (EPIC-Norfolk) BMJ 2001 322 15 10.1136/bmj.322.7277.1511141143PMC26599 Babio N Bulló M Basora J Martínez-González MA Fernández-Ballart J Márquez-Sandoval F et al. Nureta-PREDIMED Investigators Adherence to the Mediterranean diet and risk of metabolic syndrome and its components Nutr Metab Cardiovasc Dis 2009 19 563 70 10.1016/j.numecd.2008.10.00719176282 Chiva-Blanch G Badimon L Effects of polyphenol intake on metabolic syndrome: current evidences from human trials Oxid Med Cell Longev 2017 2017 5812401 10.1155/2017/581240128894509PMC5574312 Meamar R Amini M Aminorroaya A Nasri M Abyar M Feizi A Severity of the metabolic syndrome as a predictor of prediabetes and type 2 diabetes in first degree relatives of type 2 diabetic patients: a 15-year prospective cohort study World J Diabetes 2020 11 202 12 10.4239/wjd.v11.i5.20232477456PMC7243485 Venturini D Simão AN Urbano MR Dichi I Effects of extra virgin olive oil and fish oil on lipid profile and oxidative stress in patients with metabolic syndrome Nutrition 2015 31 834 40 10.1016/j.nut.2014.12.01625933490 Ghosh SS Wang J Yannie PJ Ghosh S Intestinal barrier dysfunction, LPS translocation, and disease development J Endocr Soc 2020 4 bvz039 10.1210/jendso/bvz03932099951PMC7033038 Ghoshal S Witta J Zhong J de Villiers W Eckhardt E Chylomicrons promote intestinal absorption of lipopolysaccharides J Lipid Res 2009 50 90 7 10.1194/jlr.M800156-JLR20018815435 Díaz-López A Babio N Martínez-González MA Corella D Amor AJ Fitó M et al. PREDIMED Study Investigators Mediterranean diet, retinopathy, nephropathy, and microvascular diabetes complications: a post hoc analysis of a randomized trial Diabetes Care 2015 38 2134 41 10.2337/dc15-111726370380 Hadrich F Bouallagui Z Junkyu H Isoda H Sayadi S The α-glucosidase and α-amylase enzyme inhibitory of hydroxytyrosol and oleuropein J Oleo Sci 2015 64 835 43 10.5650/jos.ess1502626235001 Conte P Fadda C Del Caro A Urgeghe PP Piga A Table olives: an overview on effects of processing on nutritional and sensory quality Foods 2020 9 514 10.3390/foods904051432325961PMC7231206 Fabiani R Anti-cancer properties of olive oil secoiridoid phenols: a systematic review of in vivo studies Food Funct 2016 7 4145 59 10.1039/c6fo00958a27713961 de Bock M Derraik JG Brennan CM Biggs JB Morgan PE Hodgkinson SC et al. Olive (Olea europaea L.) leaf polyphenols improve insulin sensitivity in middle-aged overweight men: a randomized, placebo-controlled, crossover trial PLoS One 2013 8 e57622 10.1371/journal.pone.005762223516412PMC3596374 Violi F Loffredo L Pignatelli P Angelico F Bartimoccia S Nocella C et al. Extra virgin olive oil use is associated with improved post-prandial blood glucose and LDL cholesterol in healthy subjects Nutr Diabetes 2015 5 e172 10.1038/nutd.2015.2326192450PMC4521177 Vlavcheski F Young M Tsiani E Antidiabetic effects of hydroxytyrosol: in vitro and in vivo evidence Antioxidants (Basel) 2019 8 188 10.3390/antiox806018831234300PMC6616959 Hanhineva K Törrönen R Bondia-Pons I Pekkinen J Kolehmainen M Mykkänen H et al. Impact of dietary polyphenols on carbohydrate metabolism Int J Mol Sci 2010 11 1365 402 10.3390/ijms1104136520480025PMC2871121 Rocha J Borges N Pinho O Table olives and health: a review J Nutr Sci 2020 9 e57 10.1017/jns.2020.5033354328PMC7737178 López-López A Fernández GA Montaño A Proteins and amino acids in table olives: relationship to processing and commercial presentation. Ital J Food Sci. 2007;19:217–28. Mandić ML Nosić M Functional properties of dietary fibers Osijek Josip Juraj Strossmayer University 2009 Papathanasopoulos A Camilleri M Dietary fiber supplements: effects in obesity and metabolic syndrome and relationship to gastrointestinal functions Gastroenterology 2010 138 65 72.e2 10.1053/j.gastro.2009.11.04519931537PMC2903728 Pi-Sunyer X Do glycemic index, glycemic load, and fiber play a role in insulin sensitivity, disposition index, and type 2 diabetes? Diabetes Care 2005 28 2978 9 10.2337/diacare.28.12.297816306566 Wainstein J Ganz T Boaz M Bar Dayan Y Dolev E Kerem Z et al. Olive leaf extract as a hypoglycemic agent in both human diabetic subjects and in rats J Med Food 2012 15 605 10 10.1089/jmf.2011.024322512698 Meireles M Cortez-Ribeiro AC Polck D Almeida-de-Souza J Ferro-Lebres V Olive leaf tea impact on postprandial glycemia: a randomized cross-over trial Foods 2023 12 528 10.3390/foods1203052836766057PMC9914386 Camer D Yu Y Szabo A Huang XF The molecular mechanisms underpinning the therapeutic properties of oleanolic acid, its isomer and derivatives for type 2 diabetes and associated complications Mol Nutr Food Res 2014 58 1750 9 10.1002/mnfr.20130086124740831 Martínez-Lapiscina EH Clavero P Toledo E San Julián B Sanchez-Tainta A Corella D et al. Virgin olive oil supplementation and long-term cognition: the Predimed-Navarra randomized, trial J Nutr Health Aging 2013 17 544 52 10.1007/s12603-013-0027-623732551 Rus A Molina F Ramos MM Martínez-Ramírez MJ Del Moral ML Extra virgin olive oil improves oxidative stress, functional capacity, and health-related psychological status in patients with fibromyalgia: a preliminary study Biol Res Nurs 2017 19 106 15 10.1177/109980041665937027443526 Sasahara C Burns SF Miyashita M Stensel DJ Beneficial effects of combined olive oil ingestion and acute exercise on postprandial TAG concentrations in healthy young women Br J Nutr 2012 108 1773 9 10.1017/S000711451100738022264653 Sotiroudis TG Kyrtopoulos SA Anticarcinogenic compounds of olive oil and related biomarkers Eur J Nutr 2008 47 69 72 10.1007/s00394-008-2008-918458836